← Legend Biotech Corp
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net Income | — | — | — | — | — | ($446.3m) |
($518.3m)
-16.12%
|
($177.0m)
+65.85%
|
($296.8m)
-67.68%
|
($236.5m)
+20.32%
|
|
| Net Income From Continuing Operations | — | — | — | — | — | ($445.7m) | ($520.2m) | ($158.1m) | ($282.6m) | ($236.5m) | |
| Purchase Of Financial Assets Measured At Fair Value Through Profit Or Loss Classified As Investing Activities | — | — | — | — | — | — | — | $149.2m | $0 | — | |
| Fair value gains on financial assets measured at fair value change through profit or loss | — | ($89k) | ($474k) | ($47k) | $0 | ($593k) | ($663k) | $0 | $0 | — | |
| Purchase of financial assets measured at fair value through profit or loss | — | — | ($314.8m) | ($22.7m) | ($50.0m) | ($285.0m) | $0 | ($149.2m) | $0 | — | |
| Cash received from withdrawal of financial assets measured at fair value through profit or loss | — | — | $320.9m | $22.7m | $50.1m | $100.0m | $185.0m | $149.2m | $0 | — | |
| Profit or Loss | — | — | ($133.0m) | ($303.5m) | ($403.6m) | ($446.3m) | ($518.3m) | ($177.0m) | ($296.8m) | — | |
| Other Adjustments To Reconcile Profit Loss | — | — | — | — | — | — | — | — | $1.3m | — | |
| Depreciation of property, plant and equipment | — | $845k | $4.0m | $8.2m | $11.0m | $10.2m | $10.7m | $10.7m | $9.4m | $39.4m | |
| Depreciation of right-of-use assets | — | $823k | $1.2m | $1.5m | $1.5m | $5.7m | $7.8m | $10.7m | $19.5m | $39.4m | |
| Amortization Cash Flow | — | — | — | — | $1.4m | $2.5m | $1.9m | $1.9m | — | — | |
| Amortization Of Intangibles | — | — | — | — | $1.4m | $2.5m | $1.9m | $1.9m | — | $908k | |
| Depreciation | — | — | — | — | — | $15.9m | $18.5m | $21.4m | $28.9m | $39.4m | |
| Equity-settled share-based compensation expense | — | $704k | $1.3m | $4.8m | $20.2m | $34.3m | $47.7m | $68.9m | $64.6m | — | |
| Loss on asset impairment | — | — | — | — | — | — | $0 | $4.4m | $0 | — | |
| Asset Impairment Charge | — | — | — | — | — | $0 | $0 | $4.4m | $0 | $0 | |
| Cash flows from (used in) operations before changes in working capital | — | ($12.7m) | ($128.9m) | ($211.8m) | ($340.5m) | ($402.5m) | ($368.1m) | ($198.2m) | ($40.7m) | — | |
| Change In Working Capital | — | — | — | — | — | $181.0m | ($72.7m) | $18.4m | ($93.1m) | ($94.4m) | |
| (Increase)/decrease in trade receivables | — | $207.6m | ($3.8m) | ($45.0m) | $24.6m | $50.3m | ($99.0m) | $93.8m | ($5.7m) | — | |
| Increase in prepayments, other receivables and other assets | — | ($2.5m) | ($3.9m) | $3.4m | ($3.0m) | ($50.6m) | ($8.7m) | ($61.7m) | ($126.8m) | — | |
| Change In Receivables | — | — | — | — | — | $50.3m | ($99.0m) | $93.8m | ($5.7m) | ($200k) | |
| Changes In Account Receivables | — | — | — | — | — | $50.3m | ($99.0m) | $93.8m | ($5.7m) | ($200k) | |
| Provision for inventory reserve | — | — | — | — | $0 | $5.3m | $3.6m | $12.7m | ($3.0m) | — | |
| Increase in collaboration inventories | — | ($1.1m) | ($22k) | ($643k) | $51k | ($8.6m) | ($12.7m) | ($17.2m) | ($4.5m) | — | |
| Change In Inventory | — | — | — | — | — | ($13.9m) | ($12.7m) | ($17.2m) | ($4.5m) | ($600k) | |
| Increase/(decrease) in trade payables | — | $3.2m | $2.0m | ($4.3m) | $1.8m | $25.9m | ($12.7m) | $14.1m | $44.4m | — | |
| Increase/(decrease) in other payables and accruals | — | $18.3m | $31.7m | $20.2m | $142.1m | $165.9m | ($38.8m) | $45.7m | $36.1m | — | |
| Other assets and liabilities, net | — | — | — | — | — | — | $600k | ($4.8m) | $3.4m | — | |
| Change In Other Current Assets | — | — | — | — | ($1.2m) | $3.7m | $753k | ($4.6m) | — | ($3.7m) | |
| Change In Other Current Liabilities | — | — | — | — | ($158k) | ($163k) | ($176k) | ($55k) | — | $1k | |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||||
| Purchase of property, plant and equipment | — | ($21.0m) | ($38.6m) | ($45.7m) | ($43.9m) | ($20.9m) | ($20.1m) | ($14.1m) | ($28.6m) | — | |
| Net Other Investing Changes | — | — | — | — | — | ($14.7m) | ($97.9m) | ($54.4m) | ($38.8m) | ($41.8m) | |
| Proceeds From Borrowings Classified As Financing Activities | — | — | $2.9m | — | — | — | — | — | — | — | |
| Repayments Of Borrowings Classified As Financing Activities | — | — | $2.9m | — | — | — | — | — | — | — | |
| Net Issuance Payments Of Debt | — | — | — | — | — | ($2.6m) | ($3.8m) | ($4.0m) | ($3.6m) | ($4.1m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | ($2.6m) | ($3.8m) | ($4.0m) | ($3.6m) | ($4.1m) | |
| Long Term Debt Payments | — | — | — | — | — | ($2.6m) | ($3.8m) | ($4.0m) | ($3.6m) | ($4.1m) | |
| Repayment Of Debt | — | — | — | — | — | ($2.6m) | ($3.8m) | ($4.0m) | ($3.6m) | ($4.1m) | |
| Issuance Of Capital Stock | — | — | — | — | — | $377.6m | $583.7m | $0 | $0 | $0 | |
| Common Stock Issuance | — | — | — | — | — | $377.6m | $583.7m | $0 | $0 | $0 | |
| Net cash (used in) provided by financing activities | — | $2.5m |
$14.7m
+486.41%
|
$618.9m
+4119.82%
|
$626.7m
+1.26%
|
$378.0m
-39.68%
|
$791.5m
+109.40%
|
$5.7m
-99.28%
|
($300k)
-105.27%
|
— | |
| NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS | $207.9m | ($127.1m) | $371.7m | $233.2m | $491.7m | ($991.0m) | $615.2m | ||||
| Beginning Cash Position | — | — | — | — | — | $688.9m | $786.0m | $1.3b | $286.7m | $441.7m | |
| Cash and cash equivalents at beginning of year | $2.1m | $210.2m | $83.4m | $455.7m | $688.9m | $786.0m | $1.3b | $286.7m | $901.9m | $441.7m | |
| Effect of foreign exchange rate changes, net | — | $124k | $249k | $620k | $34k | ($2.5m) | $682k | ($2.1m) | $6.1m | — | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | ($2.5m) | $700k | ($2.1m) | $6.1m | $3.5m | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Additional Financial Items | |||||||||||
| Adjustments For Current Tax Of Prior Period | — | — | ($6.6m) | $658k | $1k | $0 | — | — | — | — | |
| Adjustments For Decrease Increase In Trade Account Receivable | — | — | ($3.8m) | ($45.0m) | $24.6m | $50.3m | ($99.0m) | $93.8m | ($5.7m) | — | |
| Adjustments For Finance Costs | — | $82k | $223k | $4.2m | $900k | $10.8m | $21.8m | $21.6m | $21.4m | — | |
| Adjustments For Finance Income | — | — | $4.6m | $2.9m | $971k | $8.2m | $54.5m | $61.2m | $40.1m | — | |
| Adjustments For Unrealised Foreign Exchange Losses Gains | — | — | ($250k) | ($66k) | $4.9m | $9.2m | $28.2m | ($109.3m) | $168.8m | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | $5.1m | $2.6m | $1.4m | $2.6m | $3.8m | $4.0m | $3.6m | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | — | — | $534k | $4.0m | $3.2m | $1.3m | $2.6m | $0 | $0 | — | |
| Loss before tax | — | ($1.6m) | ($130.4m) | ($307.6m) | ($386.2m) | ($445.7m) | ($520.1m) | ($158.1m) | ($282.6m) | — | |
| Finance income | — | ($6.2m) | ($4.6m) | ($2.9m) | ($971k) | ($8.2m) | ($54.5m) | ($61.2m) | ($40.1m) | — | |
| Fair value loss of warrant liability | — | — | — | — | $6.2m | ($20.9m) | $85.8m | $0 | $0 | — | |
| Foreign currency exchange loss/(gain), net | — | ($7.2m) | ($250k) | ($66k) | $4.9m | $9.2m | $28.2m | ($109.3m) | $168.8m | — | |
| Other, net | — | — | — | — | — | — | $1.6m | $1.5m | $1.3m | — | |
| (Decrease)/increase in contract liabilities, net | — | — | — | — | — | $0 | $100.0m | ($49.7m) | ($40.0m) | — | |
| Interest income received | — | $1.8m | $9.0m | $3.4m | $652k | $5.6m | $47.3m | $37.3m | $52.0m | — | |
| Income tax received | — | — | — | $7.4m | $557k | $3.7m | $976k | $0 | $0 | — | |
| Purchase of intangible assets | — | ($63k) | ($534k) | ($4.0m) | ($3.2m) | ($1.3m) | ($2.6m) | $0 | $0 | — | |
| Payment to collaborator for collaboration assets | — | — | — | — | — | — | ($98.8m) | ($54.9m) | ($38.8m) | — | |
| Purchase of equity instruments | — | — | — | — | — | — | $0 | $0 | ($5.0m) | — | |
| Cash receipts of investment income | — | — | — | $47k | $0 | $1.3m | $8.8m | $2.5m | $0 | — | |
| Addition in time deposits | — | — | ($75.6m) | ($50.0m) | ($298.1m) | ($370.0m) | ($4.9b) | ($2.6b) | ($4.5b) | — | |
| Decrease in time deposits | — | — | — | $75.6m | $180.0m | $483.6m | $4.9b | $1.8b | $5.3b | — | |
| Decrease in pledged deposits | — | — | $255k | $0 | $0 | $105k | $907k | $516k | $0 | — | |
| Proceeds from issuance of ordinary shares for institutional investors, net of issuance cost | — | — | — | — | $0 | $0 | $234.4m | $0 | $0 | — | |
| Proceeds from issuance of ordinary shares for follow on public offering, net of issuance costs | — | — | — | $0 | $323.4m | $377.6m | $349.3m | $0 | $0 | — | |
| Proceeds from exercise of warrant by warrant holder, net of issuance cost | — | — | — | — | $0 | $0 | $199.7m | $0 | $0 | — | |
| Proceeds from exercise of share options | — | — | — | $1.5m | $4.6m | $2.9m | $11.8m | $9.7m | $3.3m | — | |
| Principal portion of lease payments | — | ($219k) | ($5.1m) | ($2.6m) | ($1.4m) | ($2.6m) | ($3.8m) | ($4.0m) | ($3.6m) | — | |
| Cash and bank balances | — | $210.4m | $159.2m | $506.1m | $858.6m | $841.3m | $1.3b | $1.1b | $948.6m | — | |
| Less: Pledged deposits | — | $255k | $256k | $384k | $1.4m | $1.3m | $357k | $70k | $0 | — | |
| Time deposits | — | — | $75.6m | $50.0m | $168.2m | $54.0m | $34.7m | $840.3m | $46.7m | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | $378.0m | $791.4m | $5.7m | ($300k) | ($2.1m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | ($77.1m) | $92.9m | ($850.6m) | $709.6m | $285.0m | |
| Change In Account Payable | — | — | — | — | — | $72.4m | ($50.2m) | $14.1m | $44.4m | $16.8m | |
| Change In Other Working Capital | — | — | — | — | — | ($15k) | $100.6m | ($54.5m) | ($36.6m) | ($35.2m) | |
| Change In Payable | — | — | — | — | — | $191.7m | ($52.9m) | $58.0m | $80.5m | $16.8m | |
| Change In Prepaid Assets | — | — | — | — | — | ($50.6m) | ($8.7m) | ($61.7m) | ($126.8m) | ($85.2m) | |
| Changes In Cash | — | — | — | — | — | $99.6m | $491.0m | ($988.9m) | $609.1m | $201.2m | |
| End Cash Position | — | — | — | — | — | $786.0m | $1.3b | $286.7m | $901.9m | $642.9m | |
| Financing Cash Flow | — | — | — | — | — | $378.0m |
$791.4m
+109.38%
|
$5.7m
-99.28%
|
($300k)
-105.26%
|
($2.1m)
-600.00%
|
|
| Free Cash Flow | — | — | — | — | — | ($223.6m) | ($416.0m) | ($158.1m) | ($128.8m) | ($115.8m) | |
| Gain Loss On Investment Securities | — | — | — | — | $6.2m | ($20.9m) | $85.8m | — | — | — | |
| Gain Loss On Sale Of PPE | — | — | — | — | $974k | $481k | $226k | $2k | — | $250k | |
| Interest Received CFO | — | — | — | — | — | $5.6m | $47.3m | $37.3m | $52.0m | $52.0m | |
| Investing Cash Flow | — | — | — | — | — | ($77.1m) | $92.9m | ($850.6m) | $709.6m | $285.0m | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | — | $9.2m | $28.2m | ($109.3m) | $168.8m | $119.5m | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | ($1.3m) | ($2.6m) | $0 | $0 | $0 | |
| Net PPE Purchase And Sale | — | — | — | — | — | ($20.9m) | ($20.1m) | ($14.1m) | ($28.6m) | ($34.1m) | |
| Net Preferred Stock Issuance | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Operating Gains Losses | — | — | — | — | — | ($11.3m) | $114.0m | ($109.3m) | $168.8m | $119.5m | |
| Other Non Cash Items | — | — | — | — | — | $8.5m | ($31.1m) | ($38.1m) | ($17.4m) | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | $2.9m | $211.5m | $9.7m | $3.3m | $2.0m | |
| Provisionand Write Offof Assets | — | — | — | — | — | $5.3m | $3.6m | $12.7m | ($3.0m) | ($5.3m) | |
| Purchase Of Intangibles | — | — | — | — | — | ($1.3m) | ($2.6m) | $0 | $0 | $0 | |
| Purchase Of PPE | — | — | — | $45.7m | $42.2m | ($20.9m) | ($20.1m) | ($14.1m) | ($28.6m) | ($34.1m) | |
| Sale Of PPE | — | — | — | — | $4k | $0 | $0 | — | — | — | |
| Stock Based Compensation | — | — | — | — | — | $34.3m | $47.7m | $68.9m | $64.6m | $68.0m | |
| Unrealized Gain Loss On Investment Securities | — | — | — | — | — | ($593k) | ($700k) | $0 | $0 | $0 | |
| Net Investment Purchase And Sale | — | — | — | — | — | ($40.1m) | $213.5m | ($782.1m) | $777.0m | $360.9m | |
| Purchase Of Investment | — | — | — | — | — | ($655.0m) | ($4.9b) | ($2.7b) | ($4.5b) | ($4.8b) | |
| Sale Of Investment | — | — | — | — | — | $614.9m | $5.1b | $1.9b | $5.3b | $5.1b | |
| Cash and cash equivalents as stated in the statement of financial position | — | $210.2m | $83.4m | $455.7m | $688.9m | $786.0m | $1.3b | $286.7m | $901.9m | — | |
| Cash and cash equivalents as stated in the statement of cash flows | — | $210.2m | $83.4m | $455.7m | $688.9m | $786.0m | $1.3b | $286.7m | $901.9m | — | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | $99.6m | $491.7m | ($991.0m) | $615.2m | — | |
| Interest Paid CFO | — | — | — | — | ($142k) | ($527k) | ($1.4m) | ($1.8m) | — | ($2.2m) | |
| Income Taxes Paid Refund Classified As Operating Activities | — | — | ($15.4m) | ($7.4m) | ($557k) | ($3.7m) | ($976k) | $0 | $0 | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.